EGRIFTA WR

Trademark usage description

pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain inj Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, nonalcoholic steathohepatitis and nonalcoholic fatty liver disease.

Classification kind code

Mark Details

Serial Number

2159097

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 7^th Feb 2025	Approved
Submitted for opposition 27 on 7^th Feb 2025	Approval Notice Sent
Submitted for opposition 22 on 30^th Jan 2025	Search Recorded
Submitted for opposition 88 on 10^th Dec 2024	Security Interest Placed
Submitted for opposition 287 on 13^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 10^th Jan 2022	Filed
Submitted for opposition 1 on 10^th Jan 2022	Created
Submitted for opposition 31 on 10^th Jan 2022	Formalized